RlapsRisk BC is intended to be used with WSI from standard stained slides coming from formalin-fixed, paraffin-embedded invasive breast carcinoma tissue specimens, and standard clinicopathological factors.
RlapsRisk BC estimates the risk of experiencing a DRFI event after surgery under 5 years of standard endocrine treatment alone for patients with ER+/HER2- early breast cancer.
RlapsRisk BC :
- provides a binary classification between "low risk" and "high risk" of experiencing a DRFI event after
surgery under 5 years of adjuvant endocrine therapy alone
- estimates the individual’s risk of experiencing a distant relapse within 5 and 10 years, based on observations from a reference dataset
• Application can be launched from Sectra's pathology image window: Yes
• Results will be shown in Sectra's pathology image window: Yes
Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.
Contact usAre you interested in learning more? Please do not hesitate to get in touch with us at Sectra.
The application content is provided by the respective AI vendors.
